Viva Biotech Holdings Management
Management criteria checks 3/4
Viva Biotech Holdings' CEO is Chen Cheney Mao, appointed in Jul 2018, has a tenure of 5.75 years. total yearly compensation is CN¥2.76M, comprised of 52.7% salary and 47.3% bonuses, including company stock and options. directly owns 8.65% of the company’s shares, worth €12.36M. The average tenure of the management team and the board of directors is 3 years and 5 years respectively.
Key information
Chen Cheney Mao
Chief executive officer
CN¥2.8m
Total compensation
| CEO salary percentage | 52.7% |
| CEO tenure | 5.8yrs |
| CEO ownership | 8.7% |
| Management average tenure | 3yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥116m |
| Sep 30 2023 | n/a | n/a | -CN¥276m |
| Jun 30 2023 | n/a | n/a | -CN¥436m |
| Mar 31 2023 | n/a | n/a | -CN¥482m |
| Dec 31 2022 | CN¥3m | CN¥1m | -CN¥528m |
| Sep 30 2022 | n/a | n/a | -CN¥209m |
| Jun 30 2022 | n/a | n/a | CN¥111m |
| Mar 31 2022 | n/a | n/a | CN¥199m |
| Dec 31 2021 | CN¥2m | CN¥1m | CN¥288m |
| Sep 30 2021 | n/a | n/a | CN¥258m |
| Jun 30 2021 | n/a | n/a | CN¥228m |
| Mar 31 2021 | n/a | n/a | -CN¥79m |
| Dec 31 2020 | CN¥1m | CN¥957k | -CN¥387m |
| Sep 30 2020 | n/a | n/a | -CN¥349m |
| Jun 30 2020 | n/a | n/a | -CN¥311m |
| Mar 31 2020 | n/a | n/a | -CN¥23m |
| Dec 31 2019 | CN¥1m | CN¥954k | CN¥266m |
Compensation vs Market: Chen Cheney's total compensation ($USD381.14K) is below average for companies of similar size in the German market ($USD678.96K).
Compensation vs Earnings: Chen Cheney's compensation has increased whilst the company is unprofitable.
CEO
Chen Cheney Mao (60 yo)
5.8yrs
Tenure
CN¥2,762,000
Compensation
Dr. Chen Cheney Mao, Ph D has been Chairman of Viva Biotech Holdings since July 03, 2018 and served as Chief Executive Officer of Viva Biotech Holdings since July 03, 2018 until December 1, 2023. He Founde...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5.8yrs | CN¥2.76m | 8.65% CN¥ 12.4m | |
| Executive VP & Executive Director | 5.8yrs | CN¥3.07m | 0.80% CN¥ 1.1m | |
| Executive Director | less than a year | CN¥3.72m | 0.69% CN¥ 987.8k | |
| Co-Chief Financial Officer | less than a year | no data | no data | |
| Co-Chief Financial Officer | less than a year | no data | no data | |
| Chief Technology Officer | 4.7yrs | no data | no data | |
| Chief Scientific Officer | 5.8yrs | no data | no data | |
| Chief Innovation Officer & Head of Viva BioInnovator | no data | no data | no data | |
| Senior Vice President | no data | no data | no data | |
| Senior VP & CEO of Langhua Pharmaceutical | no data | no data | no data | |
| Senior Vice President | no data | no data | no data | |
| Senior Vice President | 1.4yrs | no data | no data |
3.0yrs
Average Tenure
60yo
Average Age
Experienced Management: VB0's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5.8yrs | CN¥2.76m | 8.65% CN¥ 12.4m | |
| Executive VP & Executive Director | 14.6yrs | CN¥3.07m | 0.80% CN¥ 1.1m | |
| Executive Director | 5.8yrs | CN¥3.72m | 0.69% CN¥ 987.8k | |
| Independent Non-Executive Director | 5yrs | CN¥216.00k | no data | |
| Independent Non-Executive Director | 5yrs | CN¥216.00k | no data | |
| Independent Non-Executive Director | 5yrs | CN¥216.00k | no data | |
| Non-Executive Director | 1.4yrs | CN¥30.00k | no data | |
| Non-Executive Director | less than a year | no data | 3.97% CN¥ 5.7m |
5.0yrs
Average Tenure
60yo
Average Age
Experienced Board: VB0's board of directors are considered experienced (5 years average tenure).